Back
John Hancock Financial Opportunities Fund Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
37
BTO
John Hancock Financial Opportunities Fund
Last Price:
26.45
Seasonality Move:
-0.3%
Sell
50
COLL
Collegium Pharmaceutical
Last Price:
31.76
Seasonality Move:
-12.02%
Sell
37
John Hancock Financial Opportunities Fund (BTO)
is a Sell
Is John Hancock Financial Opportunities Fund a Buy, Sell or Hold?
- The current John Hancock Financial Opportunities Fund [BTO] share price is $26.47. The Score for BTO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BTO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $31.76. The Score for COLL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BTO Stock Price Chart
What is John Hancock Financial Opportunities Fund's stock price today?
-
The John Hancock Financial Opportunities Fund share price today is $26.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTO is experiencing selling pressure, which indicates risk of future bearish movement.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $31.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COLL is experiencing slight selling pressure.
BTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 33.47 | Sell |
Chaikin Money Flow: | -65218 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.46 - 28.66) | Sell |
Bollinger Bands (100): | (27.39 - 29.31) | Sell |
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 40.72 | Sell |
Chaikin Money Flow: | -11092 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.89 - 33.91) | Sell |
Bollinger Bands (100): | (32.85 - 38.01) | Sell |
BTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.57 | Sell |
20-day SMA: | 27.89 | Sell |
50-day SMA: | 27.87 | Sell |
200-day SMA: | 27.84 | Sell |
8-day EMA: | 27.42 | Sell |
20-day EMA: | 27.76 | Sell |
50-day EMA: | 27.99 | Sell |
200-day EMA: | 28.43 | Sell |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.22 | Sell |
20-day SMA: | 32.9 | Sell |
50-day SMA: | 34.83 | Sell |
200-day SMA: | 30.58 | Buy |
8-day EMA: | 32.24 | Sell |
20-day EMA: | 32.94 | Sell |
50-day EMA: | 34.18 | Sell |
200-day EMA: | 31.57 | Buy |
John Hancock Financial Opportunities Fund Earnings Growth & BTO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.04 per share, an increase this year of $0.76 per share, and an increase next year of $0.67 per share.
John Hancock Financial Opportunities Fund Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Collegium Pharmaceutical Technical Analysis
Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |